Table of Contents:

1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.4.1 Assumptions
1.4.2 Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.1.1 Introduction
3.1.2 Development of New Drugs and Therapies
3.1.3 Financial Support from CFF in Research and Development of CF Drugs.
3.2 Restraints
3.2.1 Introduction
3.2.2 High Cost of the Drugs and Treatment
3.3 Opportunities
3.4 Challenges
3.4.1 Awareness About the Rare Disease in the Developing Countries
4 Market Factor Analysis
4.1 Porter's Five Forces Model
4.1.1 Bargaining Power of Suppliers
4.1.2 Bargaining Power of Buyers
4.1.3 Threat of New Entrants
4.1.4 Threat of Substitutes
4.1.5 Intensity of Rivalry
5 Cystic Fibrosis Market, By Treatment Method
5.1 Introduction
5.2 Medication
5.3 Devices
5.4 Other Treatments
6 Cystic Fibrosis Market, By Regions
6.1 Introduction
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Middle East & Africa
7 Company Share Analysis
8 Company Profile
8.1 AbbVie
8.1.1 Company Overview
8.1.2 Product Overview
8.1.3 Financials
8.1.4 Key Developments
8.2 Allergan Plc
8.2.1 Company Overview
8.2.2 Product Overview
8.2.3 Financials
8.2.4 Key Developments
8.3 Chiesi Farmaceutici S.p.A.
8.3.1 Company Overview
8.3.2 Product/Business Segment Overview
8.3.3 Financials
8.3.4 Key Developments
8.4 F. Hoffmann-La Roche AG
8.4.1 Company Overview
8.4.2 Product/Business Segment Overview
8.4.3 Financials
8.4.4 Key Developments
8.5 Gilead Sciences
8.5.1 Company Overview
8.5.2 Product Overview
8.5.3 Financials
8.5.4 Key Developments
8.6 Novartis AG
8.6.1 Company Overview
8.6.2 Product Overview
8.6.3 Financials
8.6.4 Key Developments


8.7 Pharmaxis Ltd.
8.7.1 Company Overview
8.7.2 Product Overview
8.7.3 Financials
8.7.4 Key Developments
8.8 PTC Therapeutics
8.8.1 Company Overview
8.8.2 Product Overview
8.8.3 Financials
8.8.4 Key Developments
8.9 Vertex Pharmaceuticals Incorporated
8.9.1 Company Overview
8.9.2 Product/Business Segment Overview
8.9.3 Financials